Phenothiazine class drugs

14 results
  • chlorpromazine hydrochloride

    (chlorpromazine hydrochloride)
    Chartwell RX, LLC
    This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgery restlessness, addressing acute intermittent porphyria, adjunctive treatment of tetanus, controlling manic-depressive illness symptoms, relieving intractable hiccups, and treating severe behavioral issues in children aged 1 to 12.
  • chlorpromazine hydrochloride

    (CHLORPROMAZINE HYDROCHLORIDE)
    Eugia US LLC
    This drug is indicated for treating schizophrenia, controlling nausea and vomiting, relieving pre-surgical anxiety, managing acute intermittent porphyria, aiding tetanus treatment, addressing manic-depressive illness, alleviating severe hiccups, and managing severe behavioral issues in children aged 1 to 12 with hyperactivity and conduct disorder symptoms.
  • fluphenazine hydrochloride

    (Fluphenazine Hydrochloride)
    Glenmark Pharmaceuticals Inc., USA
    Fluphenazine hydrochloride tablets are indicated for managing symptoms of psychotic disorders. They are not effective for behavioral complications associated with mental retardation.
  • fluphenazine hydrochloride

    (Fluphenazine hydrochloride)
    Ajanta Pharma USA Inc.
    Fluphenazine hydrochloride tablets are indicated for managing manifestations of psychotic disorders. However, they are not effective for behavioral complications in patients with mental retardation.
  • fluphenazine hydrochloride

    (fluphenazine hydrochloride)
    Chartwell RX, LLC
    Fluphenazine hydrochloride tablets are indicated for managing manifestations of psychotic disorders but are not effective for behavioral complications in patients with mental retardation.
  • perphenazine

    (Perphenazine)
    Chartwell RX, LLC
    Perphenazine is indicated for the treatment of schizophrenia and the control of severe nausea and vomiting in adults. It is not effective for managing behavioral complications in patients with mental retardation.
  • prochlorperazine maleate

    (Prochlorperazine Maleate)
    JUBILANT CADISTA PHARMACEUTICALS INC.
    Prochlorperazine is indicated for controlling severe nausea and vomiting, treating schizophrenia, and short-term management of generalized non-psychotic anxiety. It should not exceed 20 mg/day or be used for more than 12 weeks to mitigate risks of persistent tardive dyskinesia. Its effectiveness is not established for other non-psychotic conditions.
  • prochlorperazine maleate

    (PROCHLORPERAZINE MALEATE)
    GLENMARK PHARMACEUTICALS INC., USA
    Prochlorperazine is indicated for controlling severe nausea and vomiting, treating schizophrenia, and short-term management of generalized non-psychotic anxiety. It should not exceed 20 mg per day or be used longer than 12 weeks to avoid risks like tardive dyskinesia.
  • prochlorperazine maleate

    (Prochlorperazine Maleate)
    Ajanta Pharma USA Inc.
    Prochlorperazine is indicated for the control of severe nausea and vomiting, treatment of schizophrenia, and short-term management of generalized non-psychotic anxiety. However, it is not the first-line treatment for anxiety due to potential risks, and its use should be limited to specific doses and duration to avoid severe side effects.